Literature DB >> 32601578

Balloon Retrograde Transvenous Obliteration for Treatment of Persistent Gastric Variceal Bleed in Patient With Hepatocellular Carcinoma.

Jaimy Villavicencio Kim1, Ismail Elkhattib1, Daniela Guerrero Vinsard1.   

Abstract

Gastric varices are often associated with formation of spontaneous portosystemic shunts that arise to relieve portal hypertension. Balloon retrograde transvenous obliteration (BRTO) is a procedure indicated to prevent recurrent gastric variceal bleeding. Its advantage is diverting blood flow towards the liver, but this can also worsen portal pressure and increase risk for ascites or esophageal variceal bleeding. Patients with gastric varices and concomitant hepatocellular carcinoma (HCC) usually have more advanced cirrhosis and lower possibility of treatment of HCC. BRTO is thought to preserve hepatic function from increased blood flow, possibly allowing better chances of treatment and survival in these patients.
Copyright © 2020, Villavicencio Kim et al.

Entities:  

Keywords:  brto; gastric varices; gi bleed; hepatocellular carcinoma

Year:  2020        PMID: 32601578      PMCID: PMC7317128          DOI: 10.7759/cureus.8796

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  7 in total

1.  Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma.

Authors:  Jung Hee Kim; Dong Hyun Sinn; Kyunga Kim; Wonseok Kang; Geum-Youn Gwak; Yong-Han Paik; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik
Journal:  Dig Dis Sci       Date:  2016-07-19       Impact factor: 3.199

2.  Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases.

Authors:  Guadalupe Garcia-Tsao; Juan G Abraldes; Annalisa Berzigotti; Jaime Bosch
Journal:  Hepatology       Date:  2016-12-01       Impact factor: 17.425

3.  Transjugular Intrahepatic Portosystemic Shunt (TIPS) versus Balloon-occluded Retrograde Transvenous Obliteration (BRTO) for the Management of Gastric Varices.

Authors:  Wael E A Saad; Michael D Darcy
Journal:  Semin Intervent Radiol       Date:  2011-09       Impact factor: 1.513

4.  The History and Evolution of Balloon-occluded Retrograde Transvenous Obliteration (BRTO): From the United States to Japan and Back.

Authors:  Wael E A Saad
Journal:  Semin Intervent Radiol       Date:  2011-09       Impact factor: 1.513

5.  Balloon-occluded retrograde transvenous obliteration for treatment of bleeding gastric varices: case report and review of literature.

Authors:  Sana Basseri; Christopher B Lightfoot
Journal:  Radiol Case Rep       Date:  2016-10-21

6.  The impact of esophagogastric varices on the prognosis of patients with hepatocellular carcinoma.

Authors:  Wei-Yao Hsieh; Ping-Hsien Chen; I-Yen Lin; Chien-Wei Su; Yee- Chao; Teh-Ia Huo; Yi-Hsiang Huang; Ming-Chih Hou; Han-Chieh Lin; Jaw-Ching Wu
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

Review 7.  Update on the management of gastrointestinal varices.

Authors:  Umesha Boregowda; Chandraprakash Umapathy; Nasir Halim; Madhav Desai; Arpitha Nanjappa; Subramanyeswara Arekapudi; Thimmaiah Theethira; Helen Wong; Marina Roytman; Shreyas Saligram
Journal:  World J Gastrointest Pharmacol Ther       Date:  2019-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.